|
Volumn 14, Issue 2, 2014, Pages 151-152
|
Introduction to RNA-based vaccines and therapeutics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RNA VACCINE;
DNA VACCINE;
LIVE VACCINE;
NEUTRALIZING ANTIBODY;
NUCLEIC ACID;
PLASMID DNA;
SMALLPOX VACCINE;
SUBUNIT VACCINE;
VIRAL PROTEIN;
VIRULENCE FACTOR;
VIRUS VECTOR;
RNA;
ANTIBODY RESPONSE;
ANTIGEN SPECIFICITY;
CELLULAR IMMUNITY;
CHICKENPOX;
DRUG DELIVERY SYSTEM;
DRUG DEVELOPMENT;
DRUG MANUFACTURE;
DRUG SAFETY;
EDITORIAL;
HOST;
HUMAN;
HUMORAL IMMUNITY;
IMMUNE RESPONSE;
IMMUNIZATION;
INFECTION PREVENTION;
INFLUENZA;
MEASLES;
MUMPS;
NONHUMAN;
PATHOGENICITY;
POLIOMYELITIS;
PRIORITY JOURNAL;
ROTAVIRUS;
RUBELLA;
TUBERCULOSIS;
TYPHOID FEVER;
VACCINATION;
YELLOW FEVER;
ANTIGEN EXPRESSION;
CLINICAL EFFECTIVENESS;
CLINICAL EVALUATION;
CLINICAL TRIAL (TOPIC);
ELECTROPORATION;
GENE TARGETING;
IMMUNITY;
POXVIRIDAE;
ROTAVIRUS INFECTION;
T LYMPHOCYTE;
VIRUS GENOME;
GENE VECTOR;
IMMUNOLOGY;
GENETIC VECTORS;
HUMANS;
RNA;
VACCINES, DNA;
|
EID: 84921345772
PISSN: 14760584
EISSN: 17448395
Source Type: Journal
DOI: 10.1586/14760584.2015.1001244 Document Type: Editorial |
Times cited : (7)
|
References (0)
|